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MK801 (dizocilpine), a phencyclidine (PCP) derivative, is a potent noncompetitive antagonist of the N-
Methyl-D-aspartate receptor (NMDAr). Another PCP derivative, ketamine, was reported to block
voltage-gated Kþ (Kv) channels, which was independent of NMDAr function. Kv currents are major
regulators of the membrane potential (Em) and excitability of muscles and neurons. Here, we investi-
gated the effect of MK801 on the Kv channels and Em in rat mesenteric arterial smooth muscle cells
(RMASMCs). We used the whole-cell patch clamp technique to analyze the effect of MK801 enantio-
mers on Kv channels and Em. (þ)MK801 inhibited Kv channels in a concentration-dependent manner
(IC50 of 89.1 ± 13.1 mM, Hill coefﬁcient of 1.05 ± 0.08). The inhibition was voltage- and state- inde-
pendent. (þ)MK801 didn't inﬂuence steady-state activation and inactivation of Kv channels. (þ)MK801
treatment depolarized Em in a concentration-dependent manner and concomitantly decreased mem-
brane conductance. ()MK801 also similarly inhibited the Kv channels (IC50 of 134.0 ± 17.5 mM, Hill
coefﬁcient of 0.87 ± 0.09). These results indicate that MK801 directly inhibits the Kv channel in a state-
independent manner in RMASMCs. This MK801-mediated inhibition of Kv channels should be
considered when assessing the various pharmacological effects produced by MK801, such as schizo-
phrenia, neuroprotection, and hypertension.
© 2014 Japanese Pharmacological Society. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).PTA, 1,2-bis(aminophenoxy)
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MK801, a phencyclidine (PCP) derivative also known as dizo-
cilpine, is a potent noncompetitive antagonist of the N-Methyl-D-
aspartate receptor (NMDAr) (1). Because the NMDAr plays a crucial
role in mediating excitatory synaptic transmission in the central
nervous system (CNS), inhibiting NMDArs profoundly modulates
CNS function (2e6). MK801 is reported to exhibit an anticonvulsant
and neuroprotective effect during the post-ischemic period (7e9).
Experimentally, MK801 has been successfully used to generate a
schizophrenia animal model that displays both positive and nega-
tive symptoms of the disease (5,10,11). In the cardiovascular system,
MK801 induces hypertension and tachycardia (12,13), much as
ketamine does. MK801 has been reported to produce psychomotor
and anesthetic effects that are almost indistinguishable from thosevier B.V. This is an open access article under the CC BY-NC-ND license (http://
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antagonist anesthetics such as PCP and ketamine. Although many
of these MK801 effects are considered to be mediated through the
inhibition of NMDArs, the details of the underlyingmechanisms are
not fully clear.
Ketamine, which is another PCP derivative, was recently re-
ported to block voltage-gated Kþ (Kv) channel currents in rat
mesenteric arterial smooth muscle cells (RMASMCs) in state-
independent manner. Ketamine appeared to block the Kv channel
directly, and the blockade was independent of NMDArs (14). Ke-
tamine markedly depolarized the membrane potential (Em) of
RMASMCs and concomitantly lowered the membrane conductance
(Gm) (14).
Kv channels are major regulators of Em and thus of the excit-
ability of muscle cells and neurons. Kv channels play key roles in
the regulation of vascular tone, propagation of action potential in
axons, regulation of resting Em in neurons and smooth muscle cells,
activation of lymphocytes, release of neurotransmitters, and
degeneration of retinal ganglion cells (15e22). However, the effect
of MK801 on Kv-channel currents, especially in vascular smooth
muscle cells, has not yet been explored.
In this study, we investigated how MK801 affects Kv-channel
currents and Em in RMASMCs by using the whole-cell patch
clamp technique. Our results demonstrate that MK801 potently and
directly inhibited Kv currents independently of NMDArs. The re-
sults also suggest that MK801 blocks Kv channels by binding the
channels in their resting closed states. This inhibition of Kv chan-
nels by MK801 should be considered when assessing the various
pharmacological effects produced by MK801, such as schizo-
phrenia, neuroprotection, and hypertension.
2. Materials & methods
2.1. Animals and cell preparation
Male SpragueeDawley (SD) rats (9e11-weeks old) were used
in experiments. All experiments were conducted in accordance
with the National Institutes of Health guidelines for the care and
use of animals, and the Institutional Animal Care and Use Com-
mittee of Konkuk University approved this study. Rats were
sacriﬁced by exposing them to a rising concentration of carbon
dioxide or by exsanguination by severing the carotid arteries
under deep ketamine-xylazine anesthesia. Single-cell suspen-
sions of RMASMCs were prepared as previously described (14).
Brieﬂy, the second to fourth order branches of superior mesen-
teric arteries were carefully removed and placed in normal
Tyrode (NT) solution (143 mM NaCl, 5.4 mM KCl, 0.33 mM
NaH2PO4, 1.8 mM CaCl2, 0.5 mM MgCl2, 5 mM HEPES, and 11 mM
glucose, adjusted to pH 7.4 with NaOH). The arteries were cut
into small pieces and then transferred to digestion solutions. The
tissue was ﬁrst digested for 15 min in Ca2þ-free NT solution
containing 1 mg/mL papain (Sigma Chemical, St. Louis, MO, USA),
1 mg/mL bovine serum albumin, and 1 mg/mL dithiothreitol.
Ca2þ-free NT was prepared by omitting 1.8-mM CaCl2 from NT
solution. Next, the sample was incubated for 25 min in a second
digestion solution, in which 3 mg/mL collagenase (Wako, Osaka,
Japan) replaced papain. After enzyme treatment, cells were iso-
lated by gentle agitation with a ﬁre-polished glass pipette in the
Ca2þ-free NT solution.
2.2. Solutions and drugs
2.2.1. Solutions
NT was used as the bath solution, and the pipette internal
solution contained 140 mM KCl, 5 mM NaCl, 5 mM MgATP, 10 mMHEPES, and 10 mM 1,2-bis(aminophenoxy)ethane-N,N,N0,N0-tet-
raacetic acid (BAPTA), adjusted to pH 7.2 with KOH. To isolate Kv-
channel currents, big conductance Ca2þ-activated Kþ (BKCa) cur-
rents were inhibited by adding 1 mM tetraethylammonium (TEA)
to the bath solution and a high concentration of the fast calcium
chelator BAPTA (10 mM) to the pipette solutions. ATP-sensitive Kþ
channels were inhibited by including 5 mMMg-ATP in the pipette
solution.2.2.2. Drugs
All chemicals including the (þ)MK801 and ()MK801 enantio-
mers were purchased from Sigma Chemical.2.3. Electrophysiological recordings
We used the conventional whole-cell conﬁguration of the patch
clamp technique to record membrane currents and Em by using an
EPC8 (HEKA, Mahone Bay, Canada) patch clamp ampliﬁer. Data
were digitized using custom-built software (R-clamp, by Dr. Ryu SY)
at a sampling rate of 5 kHz, low-pass ﬁltered at 1 kHz, and then
stored on a computer. Voltage pulse generation was also controlled
using R-clamp software. Patch pipettes were pulled from borosili-
cate capillary tubes (Clark Electromedical Instruments, Pan-
gbourne, UK) by using a PP-83 puller (Narishige, Tokyo, Japan). We
used patch pipettes with a resistance of 2e4 MU when ﬁlled with
the pipette solution listed above. Recordings were started 4e6 min
after establishing the whole-cell conﬁguration to allow adequate
cell dialysis of the pipette solution. The liquideliquid junction po-
tential between the NT and pipette solutions (calculated from ion
mobilities) was approximately 4.5 mV at 25 C. This junction
potential was not corrected for when analyzing data. Therefore, the
true Em values might be 4e5 mV more negative (hyperpolarized)
than those reported here. All experiments were conducted at room
temperature (20e25 C).2.4. Data analysis
Origin 6.0 software (Microcal Software, Inc., Northampton, MA,
USA) was used for data analysis. Half-inhibition concentration
(IC50) and Hill coefﬁcients (n) were obtained by ﬁtting concen-
trationeresponse data to the Logistic function in the Origin
software.
Activation kinetics was calculated by ﬁtting the data to a single
exponential. The time course of current inactivation was also ﬁtted
to a single exponential function. Steady-state activation curves
were ﬁtted with the following Boltzmann equation:
y ¼ 1/{1 þ exp ((VV1/2)/k)},
where k is the slope factor, V is the test potential, and V1/2 is the
voltage at which half-maximal conductance is obtained. The
steady-state voltage dependence of inactivation was investigated
using a double-pulse voltage protocol; peak currents were
measured by applying a 250-ms test potential to þ40 mV, and 10-s
preconditioning pulses were varied from60 toþ50mV (in 10-mV
steps) in the presence and absence of MK801. The resulting steady-
state inactivation data were ﬁtted to the following Boltzmann
equation:
y ¼ 1/[1 þ {exp (V V1/2)/k}],
where V is the preconditioning potential, V1/2 is the potential cor-
responding to the half-inactivation point, and k is the slope value.
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The results are shown as means ± SEM. Paired or independent
Student's t tests were used to test for signiﬁcance as appropriate,
and P < 0.05 was regarded as signiﬁcant.
3. Results
3.1. (þ)MK801 inhibition of Kv-channel currents in rat MASMCs
Under the control condition, step depolarizations above40mV
from the holding potential of 70 mV elicited typical vascular
smooth muscle Kv-channel currents (14). A representative current
trace is shown in the left panel of Fig. 1A. (þ)MK801 inhibited Kv-
channel currents in a concentration-dependent manner, and the
peak and quasi steady-state currents (measured at the end of the
test pulses) showed a similar degree of suppression during the
voltage step pulses. This (þ)MK801-dependent inhibition was
rapidly reversible; the time course of current blockage by (þ)
MK801 and recovery on washout are shown in Fig. 1B. Fig. 1CFig. 1. Effects of (þ)MK801 on voltage-dependent Kþ (Kv) currents in rat MASMCs. A. The s
and þ50 mV from a holding potential of 70 mV in the absence and presence of 100 and 300
of the voltage pulses is shown in the Fig. inset. B. Time course of Kv-current inhibition by (þ)
measured during 250-ms depolarizations to þ40 mV from the holding potential of 70 mV,
bars above the trace indicate the period of (þ)MK801 application. C. Currentevoltage (IeV) re
pulses) Kv-channel currents in the presence and absence of (þ)MK801. D. Average concentra
listed in the parentheses above the symbols. The drug-induced inhibition of Kv-channel
normalized by using the control current amplitude. The smooth line represents the best ﬁttin
(þ)MK801. The degrees of inhibition of Kv-channel currents by treatment with (þ)MK801(1
current traces elicited by depolarizing pulses in the absence and presence of 4-aminopyridin
of the Kv-channel currents in the presence and absence of 4-AP and 4-AP plus (þ)MK801.presents the peak and steady-state currentevoltage (IeV) re-
lationships of Kv-channel currents in the presence and absence of
various concentrations of (þ)MK801. Fig. 1D summarizes the con-
centration dependence of the inhibition of Kv-channel currents by
(þ)MK801. The results shown in Fig. 1D were obtained at the end of
current values at þ40 mV, and were normalized to the current
amplitude in the absence of (þ)MK801. A nonlinear least-squares ﬁt
of the Logistic function to the concentrationeresponse data yielded
an apparent IC50 value and a Hill coefﬁcient of 89.1 ± 13.1 mM and
1.05 ± 0.08, respectively.
3.2. Voltage-dependency of (þ)MK801 inhibition of Kv-channel
currents
We next examined the voltage-dependency of the inhibition of
Kv-channel currents by (þ)MK801 (Fig. 1E). Drugs that interact
with channels in a state-dependent manner are known to often
show voltage-dependent effects, particularly in the voltage range of
channel activation and inactivation (23e26).To quantify the effects
of voltage on (þ)MK801-induced inhibition of the Kv-channeluperimposed current traces were elicited by 250-ms depolarizing pulses between 60
mM (þ)MK801. Tail currents were recorded with a repolarization to35 mV. The shape
MK801 application and recovery with washout. The peak values of Kv-channel currents
which were applied repetitively every 20 s, are plotted as a function of time. The solid
lationships of the peak and quasi-steady-state (at the end of the 250-ms depolarization
tion dependence of Kv-current inhibition by (þ)MK801. The numbers of cells tested are
currents was measured at the end of a 250-ms depolarizing pulse of þ40 mV and
g of the curve with the Hill equation. E. Voltage dependence of Kv-current inhibition by
00 and 300 mM) are plotted as a function of membrane potential. F. The superimposed
e (4-AP, 1 and 10 mM) and 4-AP (10 mM) plus (þ)MK801 (300 mM). G. IeV relationships
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membrane potential. (þ)MK801 inhibited Kv currents in a voltage-
independent manner (Fig. 1E).
Previous reports indicated that the ion currents recorded with
TEA (relatively selective inhibitor of BKCa channel at 1 mM) in bath
and high concentrations of Mg-ATP and Ca2þ chelators (such as
BAPTA and EGTA) in pipette were largely Kv currents in arterial
smoothmuscle cells (14,27). However, in order to verify further that
the current blocked by (þ)MK801 in this study was really the cur-
rent through Kv channels, we examined the effect of 4-
amonopyridine (4-AP). 4-AP concentration-dependently inhibited
the control current (Fig. 1F). Moreover, (þ)MK801 (300 mM) failed
to block the current in the presence of 4-AP (10 mM). Fig. 1G
summarizes the IeV relationships in the absence and presence of 4-
AP and (þ)MK801, supporting the hypothesis that the current
recorded in the present study is Kv current and that (þ)MK801
inhibited the Kv current.
Because we used hydrogen maleate salt form of MK801, we also
examined the effect of hydrogen maleate on the Kv-channel cur-
rent. However, hydrogen maleate (300 mM) did not inhibit the Kv-
channel currents at all (Supplementary Fig. 1).
3.3. Effects of (þ)MK801 on the activation and inactivation time
courses of Kv-channel currents
The traces in Fig. 2A show the effects of (þ)MK801 on the
activation time course of Kv-channel currents. The currents wereFig. 2. Activation and inactivation time courses of Kv-channel currents in the presence and
pulses to between 20 and þ50 mV from the holding potential 70 mV in the presence a
distinct. The smooth lines represent the best ﬁttings of the currents traces by single exponen
constants (t, in ms), obtained from single exponential ﬁttings. B. Summary of the activation
MK801(100 and 300 mM). C. Superimposed current traces elicited by 10-s depolarizing puls
MK801. The smooth lines represent the best ﬁttings by single exponential functions. The nu
ms). D. Summary of the inactivation time constants at þ40 mV in the presence and absence o
cells tested. **p < 0.01 vs. control; ***p < 0.001 vs. control.elicited using 50-ms-long depolarizing voltage step pulses to
between 20 mV and þ50 mV from the holding potential
of 70 mV (Fig. 2A). As shown by the control trace in Fig. 2A, the
activation time constant became smaller as depolarization became
stronger. (þ)MK801 had little effect on the activation time course of
the Kv-channel currents. The activation time constants for voltage
steps from 20 mV to þ50 mV in the presence and absence of (þ)
MK801 are presented in Fig. 2B. Next, we examined the effects of
(þ)MK801 on the inactivation time course of Kv-channel currents;
the inactivation was slow, and time course of inactivation was
examined during 10-s-long voltage steps to þ40 mV from the
holding potential of 70 mV (Fig. 2C). The traces in Fig. 2C shows
representative inactivation time courses in the presence and
absence of (þ)MK801. (þ)MK801 substantially accelerated the slow
inactivation time course of Kv-channel currents in a concentration-
dependent manner (Fig. 2C & D).
3.4. Use dependency of the inhibition of Kv-channel currents by (þ)
MK801
We examined whether (þ)MK801 inhibited Kv-channel currents
in RMASMCs in a use-dependent manner. We applied 20 repetitive
125-ms depolarizing step pulses toþ40mV from a holding potential
of 70 mV at two frequencies, 1 and 2 Hz. Use dependence was
tested after (þ)MK801 had steadily inhibited the currents. Fig. 3A
shows representative, superimposed current traces under control
conditions and in the presence of 300 mM (þ)MK801. The results areabsence of (þ)MK801. A. Superimposed currents traces elicited by 50-ms depolarizing
nd absence of (þ)MK801. The current scales in the control and (þ)MK801 groups are
tial functions. The numbers on the right of the current traces represent activation time
time constants (t) at various membrane potentials in the presence and absence of (þ)
es to þ40 mV from a holding potential of 70 mV, in the presence and absence of (þ)
mbers at the end of the currents traces represent the inactivation time constants (t, in
f (þ)MK801. The numbers in the parenthesis inside the columns indicate the number of
Fig. 3. Use dependency of Kv-current inhibition by (þ)MK801. A. Superimposed current traces elicited by 20 repetitive 125-ms depolarizing pulses to þ40 mV from a holding
potential of 70 mV (the shape of which is shown in the inset above the corresponding current traces) in the presence and absence of (þ)MK801 (300 mM). The 125-ms depolarizing
pulses were applied at a frequency of 1 Hz (left panel) and 2 Hz (right panel). B. The peak amplitudes of the Kv-channel currents measured with the two pulse-train frequencies in
the presence and absence of (þ)MK801 (100 and 300 mM) were plotted against the pulse numbers after normalizing to the peak amplitude of Kv-channel currents elicited by the
ﬁrst depolarizing pulses.
J.M. Kim et al. / Journal of Pharmacological Sciences 127 (2015) 92e10296summarized in Fig. 3B. The Kv-channel current amplitude decreased
progressively during the repetitive depolarizing pulses. The pro-
gressive decrease in peak current amplitude was slightly more
dominant in the presence of 100 and 300 mM (þ)MK801 (Fig. 3B).
The trains of repetitive voltage steps are frequently used to
examine the use and/or state dependency of ion channel blockage.
Although the data shown in Fig. 3 suggest partial use-dependent
inhibition of Kv-channel currents by (þ)MK801, the disparity in
the progressive decrease of currents in the absence and presence of
(þ)MK801 was extremely small. Moreover, the slow inactivation of
the Kv-channel current shown in Fig. 2 may be reﬂected cumula-
tively during the 20 repetitive 125-ms depolarizing step pulses.
To address the above possibility, we examined the inhibition by
the ﬁrst depolarizing voltage steps after (þ)MK801 treatment and
compared it with the steady-state inhibition. Because a small
fraction of the channels may have been spontaneously active or
inactive at the holding potential of 70 mV and (þ)MK801 might
have bound these channels, we clamped the RMASMCs at 110 mV
before and during (þ)MK801 application without the depolarizing
voltage steps (Fig. 4). The ﬁrst depolarizing pulse, applied ~2 min
after (þ)MK801 treatment, showed similar levels of (þ)MK801-
dependent inhibition of Kv-channel currents (~60% inhibition in
the presence of 300 mM (þ)MK801), and the subsequent depola-
rizing pulse did not produce further inhibition (Fig. 4). These data
indicate that the inhibition of Kv-channel currents by (þ)MK801
does not depend on the channel activation or inactivation state.
3.5. Effects of (þ)MK801 on the steady-state activation and
inactivation curves
Next, we investigated the steady-state kinetics of Kv channels in
the presence and absence of (þ)MK801. Steady-state activation of Kv
channels was measured using the conventional method by using
peak tail currents at 35 mV after various test potentials (upperpanel of Fig. 5A). Steady-state inactivation kinetics were also
examined using a conventional double-pulse protocol (upper panel
of Fig. 5B), which is explained in detail in the Data analysis sub-
section of the Methods and in the Fig. legend. The results presented
in Figs. 1, 3 and 4 suggested that (þ)MK801 is unlikely to prefer-
entially interact with and modulate the Kv channels in activated or
inactivated states in RMASMCs. In accord, (þ)MK801 had little effect
on steady-state activation and inactivation kinetics of Kv channels in
RMASMCs (Fig. 5A & B). The potential at the half-activation point
(V1/2) and the slope value (k) of the steady-state activation curves
were 8.6 ± 0.9 and 12.8 ± 0.6 mV for controls, 12.9 ± 1.2 and
10.3 ± 0.7 mV for 100 mM (þ)MK801, and 11.9 ± 1.1 and
8.0 ± 0.5 mV for 300 mM (þ)MK801, respectively. Furthermore, the
V1/2 and k values of the steady-state inactivation curves
were 30.7 ± 0.8 and 7.5 ± 0.7 mV for controls, 34.4 ± 1.3 and
8.0± 0.8mV for 100 mM (þ)MK801, and31.5± 1.5 and 6.6± 1.0mV
for 300 mM (þ)MK801, respectively.
3.6. Effects of (þ)MK801 on recovery from inactivation
The time course of the recovery from inactivation of the Kv-
channel currents in RMASMCs was also examined in the absence
and presence of (þ)MK801. The voltage-pulse protocol for
measuring the recovery from inactivation is shown in the inset in
Fig. 6A. The recovery time courses in the absence and presence of
(þ)MK801 were similar: the time constants of the recovery from
inactivation of Kv-channel currents in the absence and presence of
(þ)MK801, which were obtained by data ﬁtting to a single expo-
nential decay curve, were 311 ± 41 and 325 ± 58 ms, respectively.
3.7. Effects of ()MK801 on Kv-channel currents
()MK801, an optical isomer of (þ)MK801, is substantially less
effective than (þ)MK801 in blocking the NMDAr (9). Thus, we
Fig. 4. Effects of a hyperpolarized holding potential on Kv-current inhibition by (þ)MK801. A. The peak current amplitudes of Kv-channel currents elicited by 250-ms depolarizing
pulses to þ40 mV from a holding potential of 110 mV were plotted as a function of time. The solid line above the trace indicates the period of (þ)MK801 application. The
depolarizing pulse was not applied for 1e2 min before and during the ﬁrst 2e3 min of (þ)MK801 application, and the cell membrane potential was held at 110 mV to minimize
spontaneous channel activation and inactivation. B. Representative Kv-channel current traces evoked by 250-ms steps to þ40 mV from a holding potential of 110 mV before (left
panel) and after (right panel) 2-min treatment with (þ)MK801 at 110 mV. Similar results were observed in four additional experiments.
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rents in RMASMCs with the effects produced by (þ)MK801. ()
MK801 inhibited Kv-channel currents in a concentration-
dependent manner (Fig. 7A). The IeV relationships of the channel
currents in the presence and absence of 300 and 1000 mM ()
MK801 are shown in Fig. 7B. Fig. 7C summarizes the concentration-
dependent inhibition of Kv-channel currents by ()MK801. A
nonlinear least-squares ﬁt of the Hill equation to the concen-
trationeeffect curve of ()MK801 yielded an IC50 and a Hill coef-
ﬁcient of 134.0 ± 17.5 mM and 0.87 ± 0.09, respectively. These
results demonstrate that the inhibitory effects of (þ)MK801 and ()
MK801 are highly similar, suggesting that the actions of the MK801
enantiomers on Kv-channel currents in RMASMCs are not stereo-
speciﬁc, which is distinct from their action on the NMDAr.
3.8. Effects of (þ)MK801 on the Em and Gm
Lastly, we examined the effects of (þ)MK801 on the Em of
RMASMCs. Because Kv-channel currents are the dominant regula-
tors of resting Em in RMASMCs (28), MK801 treatment was ex-
pected to depolarize the Em of RMASMCs. Applying (þ)MK801
induced rapid and reversible depolarization of Em in a
concentration-dependent manner (Fig. 8A). Fig. 8B presents the
resting Em values in the absence and presence of various concen-
trations of (þ)MK801, and Fig. 8C summarizes the concentration-
dependent depolarizing effects. To conﬁrm that (þ)MK801-
induced Em depolarization was because of the inhibition of Kþ
channels, we measured the Gm by repetitively injecting brief
hyperpolarizing current pulses (amplitude 20 pA, duration 1 s,
interval 15e35 s), which are reﬂected as transient negative de-
ﬂections (hyperpolarizations) of Em (Fig. 8A). Gm was calculated
from Ohm's law as follows:
G ¼ I/V,where I is the amplitude of the injecting current (20 pA here)
and V is the amplitude of the transient Em hyperpolarization
resulting from current injection. The tracing of Em in Fig. 8A in-
dicates that the (þ)MK801-induced Em depolarization is associ-
ated mainly with the inhibition of Kþ conductance, and not with
the activation of a depolarizing conductance. Fig. 8D summarizes
the concentration-dependent decrease in Gm caused by (þ)
MK801.4. Discussion
The results of the present study indicate that MK801 blocks Kv
channels independently of NMDAr and that this inhibition may
depolarize the Em of vascular smooth muscle under clinical set-
tings. To the best of our knowledge, this is the ﬁrst study to
demonstrate that MK801 blocks Kv channels and depolarizes Em in
vascular smooth muscle cells. This MK801 inhibition of Kv chan-
nels, in addition to the NMDAr block, should be considered when
assessing the various pharmacological effects of MK801 such as
hypertension as well as schizophrenia.4.1. Possible involvement of Kv-channel inhibition in the various
pharmacological effects of MK801
Ketamine, which is another PCP-derivative, is similar to MK801
in structure and pharmacological action and is an effective anes-
thetic, especially in patients at risk of hypotension during anes-
thesia: unlike other anesthetics, ketamine increases blood pressure
(29). Although the hypertensive effect of ketamine is generally
considered the result of inhibition of central and peripheral cate-
cholamine reuptake (30,31) and direct stimulation of the CNS, the
exact mechanism involved remains unclear. Inhibition of BKCa and
Kv channels in vascular smooth muscle has been suggested as
Fig. 5. Effects of (þ)MK801 on steady-state activation and inactivation of Kv-channel currents. A. Activation curves under control condition and in the presence of 100 and 300 mM
(þ)MK801. The smooth lines are the best ﬁttings of a Boltzmann function. The activation curves were obtained using a conventional double-pulse protocol (inset in upper panel):
The channels were activated by applying a short depolarizing pulse to values between 60 and þ50 mV from a holding potential of 70 mV in steps of 10 mV. After the ﬁrst
activating test pulse, the second pulses were stepped to the membrane potential of 35 mV, and the peak value of the tail current was measured (upper panel, indicated by an
arrow). The normalized current amplitude was considered an estimate of channel activation and plotted as a function of the activating test-pulse potentials. B. The steady-state
inactivation curves of Kv channels under the control condition and during the application of 100 and 300 mM (þ)MK801 were obtained using a typical double-pulse protocol,
the shape of which is shown in the inset of the upper panel. The currents were activated by a test step to þ40 mV (indicated by an arrow, upper panel) after a 10-s conditioning
prepulse at various voltages. The normalized current amplitude was regarded to be an estimate of steady-state channel inactivation and was plotted as a function of the prepulse
potential (lower panel). The smooth lines represent the best ﬁttings to the Boltzmann function.
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Moreover, no study has yet examined whether or not the inhibition
of central and peripheral catecholamine reuptake and direct stim-
ulation of the CNS (30,31) involves Kv-channel inhibition. MK801 isFig. 6. Effect of (þ)MK801 on the recovery from inactivation of Kv-channel currents. A. T
prepulse of a 10-s depolarizing potential of þ40 mV from a holding potential of 70 mV wa
at 70 mV. All cycles of the double-pulse protocol lasted 10 s. B. The peak currents elicited
ﬁrst prepulse and plotted as a function of various interpulse intervals. The smooth lines repr
channel currents in the absence and presence of (þ)MK801.not administered clinically because of its critical side effect such as
the neurotoxic effects called Olney's lesions (33,34). However,
MK801 was also reported to stimulate the cardiovascular system
and increase blood pressure in experimental animals (12). The Kv-he degree of recovery was measured by following a double-pulse protocol. The ﬁrst
s followed by a second 0.5-s pulse after increasing time intervals between 0.5 and 17 s
by the second test pulse were normalized against the peak currents obtained with the
esent the best ﬁttings to the single exponential function of the recovery kinetics of Kv-
Fig. 7. Effects of ()MK801, the optical isomer of (þ)MK801, on Kv-channel currents in rat MASMCs. A. The superimposed current traces were elicited by 250-ms depolarizing pulses
between 60 and þ50 mV from a holding potential of 70 mV in the absence and presence of 100 and 300 mM ()MK801. The shape of the voltage pulses is shown in the Fig. inset.
B. IeV relationships of the peak and quasi-steady-state (at the end of the 250-ms depolarization pulses) Kv-channel currents in the presence and absence of ()MK801. C. Average
concentration dependence of Kv-current inhibition by ()MK801. The numbers in the parentheses above the symbols indicate the number of cells tested. The drug-induced in-
hibition of Kv-channel currents was measured at the end of a 250-ms depolarizing pulse of þ40 mV and normalized by using the control current amplitude. The smooth line
represents the best ﬁtting with the Hill equation. The small closed circles and dotted line are from the (þ)MK801 experiment and are redrawn from Fig. 1 for comparison with ()
MK801.
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sive effect of MK801 as in the case of ketamine.
MK801 is experimentally a potent anticonvulsant and has great
potential for use in research for generating animal models of
schizophrenia. Unlike dopaminergic agonists that mimic only the
positive symptoms of schizophrenia, a single injection of MK801
was successful in modeling both the positive and negative
symptoms of schizophrenia (11). Not only has temporary treat-
ment with MK801 been shown to mimic psychosis, but chronic
administration of the drug in laboratory animals has also been
demonstrated to result in similar neuropathological changes as in
schizophrenia (35). For MK801-induced psychosis or schizo-
phrenia, a mechanism generally accepted is the inhibition of the
NMDAr channel or the hypo-glutaminergic theory (5,36). How-
ever, the interaction of PCP derivatives (such as MK801 and ke-
tamine) and serotonin 5-HT2A receptor or dopamine D2 receptor
has also been reported (37e41). These reports suggested that
ketamine and PCP may act as agonists (or allosteric activators) of
the 5-HT2A and D2 receptors, and that the 5-HT2A and D2 receptors
are thus associated with the schizophrenia induced by PCP de-
rivatives. Recently, it was also reported that the discriminative
stimulus effect of ketamine involves the 5-HT2A receptor (42).
Both in the CNS and peripheral cardiovascular system, signaling of
the 5-HT2A receptor involves a decrease of Kv-channel conduc-
tance (22,28,43,44). Because Kv-channel subunits such as Kv1.5
function as key mediators of 5-HT2A receptor activation, we
speculate that MK801 potentiates signaling by the 5-HT2Areceptor by inhibiting Kv1.5 (44,45). Supporting this notion, in our
preliminary experiments, ketamine and MK801 selectively
potentiated 5-HT2A receptor-mediated vasoconstriction without
affecting adrenergic receptor-mediated vasoconstriction, espe-
cially at the physiological nanomolar concentration ranges of se-
rotonin and norepinephrine (unpublished observation).
Moreover, we also observed that MK801 blocked the rat brain
Kv1.5 (rKv1.5) channels heterologously expressed in Chinese
hamster ovary (CHO) cells (unpublished observation). Based on
these results, we suggest that whether Kv-channel inhibition
contributes to MK801 effects such as schizophrenia and hyper-
tension should be carefully considered. The hypothesis is sche-
matically illustrated in Supplementary Fig. 2.
In the present study, IC50 of MK801 on the Kv channel was
around 100 mM. This was surely much higher than the reported
plasma level of MK801: it was reported to be ~0.2 mM in the psy-
chosis rat model (10). However, the drug concentration of speciﬁc
area in the brain can be much higher than the average blood con-
centration (46). Moreover, just a small inhibition of Kv channels
may induce large alterations in cellular excitability. In the present
study, 10 mM of MK801 substantially depolarized Em of the arterial
smooth muscle cells (~8.1 mV, Fig. 8)
4.2. Mechanism of Kv-channel inhibition by MK801
Our analysis of MK801-induced inhibition of Kv-channel cur-
rents suggests that the drug is unlikely to interact preferentially
Fig. 8. Effects of (þ)MK801 on the membrane potential (Em) and change of membrane conductance (Gm) in rat MASMCs. To measure Gm, a hyperpolarizing current
(amplitude 20 pA, duration 1 s) was repeatedly injected. The transient hyperpolarizations (spikes) of the Em shown in panel (A) were induced by this current injection. A.
Representative recording of Em showing the effects of (þ)MK801 on Em and Gm. The increases in the amplitude of the transient hyperpolarization of Em reﬂect the decrease in Gm
calculated using Ohm's law: V ¼ I/G, where V, I, and G indicate voltage, current, and conductance, respectively. B. Summary of the effect of various concentrations of (þ)MK801 on
the Em of RMASMCs. C. Summary of the concentration-dependent depolarizing effects of (þ)MK801. D. Summary of the concentration-dependent effects of (þ)MK801 on Gm of
RMASMCs. *p < 0.05 compared to control. The numbers in the parenthesis inside each bar are the numbers of cells tested.
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following reasons. First, the inhibition was voltage-independent
(Fig. 3). Many open-channel blockers inhibit voltage-gated chan-
nels in voltage-dependent manner, especially in the activation
voltage range of the channels (47,48), because the drug-channel
interaction requires channel opening and the drug-binding site is
located in the transmembrane pore region. Second, the steady-state
activation and inactivation of Kv channels were unaffected by
MK801 treatment (Fig. 5). Although alterations in the steady-state
activation and inactivation curves are not strictly required in
state-dependent drug-channel interaction, most state-dependent
channel blockers alter the steady-state channel kinetics (such as a
left-shift of inactivation) (49,50). Third, when spontaneous channel
activation and inactivation were prevented by holding Em at a
hyperpolarized potential (110 mV), the ﬁrst depolarizing pulse
after the ~2-min treatment with MK801 produced an identical
degree and pattern of Kv-channel inhibition as in the steady-state
experiments (Fig. 4). This veriﬁes the hypothesis that MK801
binds Kv channels in their resting closed states and inhibits them
(tonic inhibition). Fourth, the use-dependency observed in this
study was minimal (Fig. 3). Although use-dependent inhibition is
typically strong evidence of state-dependent inhibition, the mini-
mal use-dependency detected here does not support the state-
dependent block theory. The slow inactivation time course was
markedly accelerated in the presence of MK801 (Fig. 2). However,
this does not appear to contribute substantially to MK801 inhibi-
tion of Kv channels because of the following observation: the
blockade reached maximal levels within 50 ms after application of
the voltage step depolarization, when slow inactivation is appar-
ently absent (Figs. 2A and 3A), which indicates that MK801
diminished the “peak” amplitude of the Kv-channel currents at the
beginning of the depolarizing pulse. Based on these results, wesuggest that MK801 inhibits Kv channels primarily by binding to
the channels in their closed states and reducing channel availability
or decreasing channel conductance.
The blockade of Kv channels by MK801 in RMASMCs reported
here is highly similar to the inhibition of the channels by ketamine
(14). The ketamine block of Kv channels was also voltage-
independent and did not alter steady-state channel kinetics.
However, MK801 inhibits Kv channels in RMASMCs more potently
(IC50 of ~100 mM) than ketamine (IC50 of ~500 mM). The optical
isomers of ketamine and MK801 showed similar potency and
maximal efﬁcacy in inhibiting the Kv channels of RMASMCs,
suggesting that the inhibition of Kv channels by these two PCP-
derivative NMDAr inhibitors is independent of the NMDAr.
Moreover, the rat mesenteric artery reportedly does not express
functional NMDArs (51). (±)Ketamine racemate has been reported
to inhibited NR1/NR2A and NR1/NR2B channels with IC50 values
of 13.6 ± 8.5 and 17.6 ± 7.2 mM, respectively, whereas S(þ)-
ketamine inhibited NR1/NR2A and NR1/NR2B with IC50 values of
4.1 ± 2.5 and 3.0 ± 0.3 mM, respectively (52). The IC50 values of (þ)
MK801 and ()MK801 for inhibiting channels with the NR1 sub-
unit and various NR2 subunit complexes (NR1/NR2X) ranged from
9e38 nM and from 32e354 nM, respectively. These IC50 values for
inhibiting NMDArs are distinct from those for inhibiting Kv of
RMASMCs.
The pKa of MK801 is 8.37, and thus approximately 94% of MK801
exists in its protonated, positively charged form at pH 7.2 (the pH of
the pipette solution). The results of this study showed that MK801
inhibition of Kv-channel currents was completely voltage-
independent (Fig. 3), which suggests that the MK801-binding site
of Kv channels is not affected by the sensing of the transmembrane
potential, unlike in the case of the binding sites for open-pore
blocking agents. In this study, we did not examine whether an
J.M. Kim et al. / Journal of Pharmacological Sciences 127 (2015) 92e102 101extra- or intra-cellular site is responsible for theMK801-Kv channel
interaction, which warrants future investigation.
As described above, MK801 is a potent NMDAr inhibitor. NMDAr
is a glutamate receptor and glutamate is the brain's primary
excitatory neurotransmitter. NMDAr is an ionotropic receptor that,
when activated, causes the inﬂux of Ca2þ and other cations. MK801
blocks the NMDAr in a state- and voltage-dependent manner,
because the PCP-binding sites in the NMDAr are accessible to
MK801 only when the channel is open or activated. Therefore, the
mechanism by which MK801 was determined to inhibit the Kv
channels of RMASMCs in this study differs considerably from the
mechanism of MK801 inhibition of the NMDAr channel.
4.3. Future study
Because we examined the effect of MK801 on native Kv-channel
currents in RMASMCs in this study, the speciﬁc target of MK801
remains unknown. Multimeric heteromers of several Kv-channel
subunits such as Kv1.1, Kv1.2, Kv1.5, and Kv2.1 have been re-
ported to contribute to the native Kv-channel currents of vascular
smooth muscle (53e55). Furthermore, certain auxiliary Kv-channel
beta subunits have been reported to contribute to the complexity
and heterogeneity of native Kv currents (56,57). These Kv-channel
subunits play critical roles in variety of excitable and non-excitable
cells such as those in the cardiovascular system and in the CNS.
Therefore, future studies could examine the effect of MK801 on
speciﬁc Kv-channel subunits expressed in heterologous cell sys-
tems. As we stated above, we have observed that MK801 blocked
the Kv1.5 expressed in CHO cells. The blockade of Kv1.5 by MK801
was very similar with that the present study. Elucidating the spe-
ciﬁc binding sites in Kv channels for MK801 would be of substantial
pharmacological use.
5. Conclusion
The results of this study indicate that MK801 directly inhibits
the Kv channel in a state-independent manner in RMASMCs. This
MK801 inhibition of Kv channels, in addition to the NMDAr block,
should be considered when assessing the various pharmacological
effects of MK801 such as schizophrenia, neuroprotection, and
hypertension.
Conﬂicts of interest
All authors declare that there is no conﬂict of interest.
Acknowledgments
This research was supported by Konkuk University.
Appendix A. Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.jphs.2014.11.005.
References
(1) Lodge D, Jones M, Fletcher E. Non-competitive antagonists of Nmethyl-D-
aspartate. In: Collingridge GL, Watkins JC, editors. The NMDA receptor.
(Oxford Univ. Press); 1994.
(2) Ayala GX, Tapia R. Late N-methyl-D-aspartate receptor blockade rescues hip-
pocampal neurons from excitotoxic stress and death after 4-aminopyridine-
induced epilepsy. Eur J Neurosci. 2005;22:3067e3076.
(3) Church J, Zeman S, Lodge D. The neuroprotective action of ketamine andMK-801
after transient cerebral ischemia in rats. Anesthesiology. 1988;69:702e709.
(4) Kocaeli H, Korfali E, Ozturk H, Kahveci N, Yilmazlar S. MK-801 improves
neurological and histological outcomes after spinal cord ischemia induced bytransient aortic cross-clipping in rats. Surg Neurol. 2005;64(Suppl. 2):
S22eS26.
(5) Manahan-Vaughan D, von Haebler D, Winter C, Juckel G, Heinemann U.
A single application of MK801 causes symptoms of acute psychosis, deﬁcits in
spatial memory, and impairment of synaptic plasticity in rats. Hippocampus.
2008;18:125e134.
(6) Mukhin AG, Ivanova SA, Knoblach SM, Faden AI. New in vitro model of
traumatic neuronal injury: evaluation of secondary injury and glutamate
receptor-mediated neurotoxicity. J Neurotrauma. 1997;14:651e663.
(7) Gill R, Foster AC, Woodruff GN. MK-801 is neuroprotective in gerbils when
administered during the post-ischaemic period. Neuroscience. 1988;25:
847e855.
(8) Troupin ASMJ, Cheng F. Risinger MW MK801. In: Meldrum BS, Porter RJ, ed-
itors. New Anticonvulsant Drugs; 1986. p. 191e201.
(9) Wong EH, Kemp JA, Priestley T, Knight AR, Woodruff GN, Iversen LL. The
anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc
Natl Acad Sci U S A. 1986;83:7104e7108.
(10) Andine P, Widermark N, Axelsson R, Nyberg G, Olofsson U, Martensson E, et al.
Characterization of MK-801-induced behavior as a putative rat model of
psychosis. J Pharmacol Exp Ther. 1999;290:1393e1408.
(11) Rung JP, Carlsson A, Ryden Markinhuhta K, Carlsson ML. (þ)-MK-801 induced
social withdrawal in rats; a model for negative symptoms of schizophrenia.
Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:827e832.
(12) Lewis SJ, Barres C, Jacob HJ, Ohta H, Brody MJ. Cardiovascular effects of the N-
methyl-D-aspartate receptor antagonist MK-801 in conscious rats. Hyper-
tension. 1989;13:759e765.
(13) Tian B, Hartle DK. Cardiovascular effects of NMDA andMK-801 infusion at area
postrema and mNTS in rat. Pharmacol Biochem Behav. 1994;49:489e495.
(14) Kim SH, Bae YM, Sung DJ, Park SW, Woo NS, Kim B, et al. Ketamine blocks
voltage-gated K(þ) channels and causes membrane depolarization in rat
mesenteric artery myocytes. Pﬂugers Arch. 2007;454:891e902.
(15) Gutterman DD, Miura H, Liu Y. Redox modulation of vascular tone: focus of
potassium channel mechanisms of dilation. Arterioscler Thromb Vasc Biol.
2005;25:671e678.
(16) Hsiao CF, Kaur G, Vong A, Bawa H, Chandler SH. Participation of Kv1 channels
in control of membrane excitability and burst generation in mesencephalic V
neurons. J Neurophysiol. 2009;101:1407e1418.
(17) Koeberle PD, Wang Y, Schlichter LC. Kv1.1 and Kv1.3 channels contribute to
the degeneration of retinal ganglion cells after optic nerve transection in vivo.
Cell Death Differ. 2010;17:134e144.
(18) Martel P, Leo D, Fulton S, Berard M, Trudeau LE. Role of Kv1 potassium
channels in regulating dopamine release and presynaptic D2 receptor func-
tion. PLoS One. 2011;6:e20402.
(19) Nelson MT, Quayle JM. Physiological roles and properties of potassium
channels in arterial smooth muscle. Am J Physiol. 1995;268:C799eC822.
(20) Panyi G, Varga Z, Gaspar R. Ion channels and lymphocyte activation. Immunol
Lett. 2004;92:55e66.
(21) Pongs O. Voltage-gated potassium channels: from hyperexcitability to
excitement. FEBS Lett. 1999;452:31e35.
(22) Sung DJ, Noh HJ, Kim JG, Park SW, Kim B, Cho H, et al. Serotonin contracts the
rat mesenteric artery by inhibiting 4-aminopyridine-sensitive Kv channels via
the 5-HT2A receptor and Src tyrosine kinase. Exp Mol Med. 2013;45:e67.
(23) Choi BH, Choi JS, Jeong SW, Hahn SJ, Yoon SH, Jo YH, et al. Direct block by
bisindolylmaleimide of rat Kv1.5 expressed in Chinese hamster ovary cells.
J Pharmacol Exp Ther. 2000;293:634e640.
(24) Delpon E, Valenzuela C, Gay P, Franqueza L, Snyders DJ, Tamargo J. Block of
human cardiac Kv1.5 channels by loratadine: voltage-, time- and use-
dependent block at concentrations above therapeutic levels. Cardiovasc Res.
1997;35:341e350.
(25) Kim A, Bae YM, Kim J, Kim B, Ho WK, Earm YE, et al. Direct block by bisin-
dolylmaleimide of the voltage-dependent Kþ currents of rat mesenteric
arterial smooth muscle. Eur J Pharmacol. 2004;483:117e126.
(26) Perchenet L, Hilﬁger L, Mizrahi J, Clement-Chomienne O. Effects of anorexi-
nogen agents on cloned voltage-gated K(þ) channel hKv1.5. J Pharmacol Exp
Ther. 2001;298:1108e1119.
(27) Son YK, Hong da H, Li H, Kim DJ, Na SH, Park H, et al. The Ca2þ channel
iinhibitor NNC 55-0396 inhibits voltage-dependent Kþ channels in rabbit
coronary arterial smooth muscle cells. J Pharmacol Sci. 2014;125:312e319.
(28) Bae YM, Kim A, Kim J, Park SW, Kim TK, Lee YR, et al. Serotonin depolarizes
the membrane potential in rat mesenteric artery myocytes by decreasing
voltage-gated Kþ currents. Biochem Biophys Res Commun. 2006;347:
468e476.
(29) Katzung B. General anesthetics. In: Basic & Clinical Pharmacology. 5th ed
1992. p. 350e362.
(30) Lundy PM, Gverzdys S, Frew R. Ketamine: evidence of tissue speciﬁc inhibition
of neuronal and extraneuronal catecholamine uptake processes. Can J Physiol
Pharmacol. 1985;63:298e303.
(31) White PF, Way WL, Trevor AJ. Ketamineeits pharmacology and therapeutic
uses. Anesthesiology. 1982;56:119e136.
(32) Han J, Kim N, Joo H, Kim E. Ketamine blocks Ca2þ-activated Kþ channels in
rabbit cerebral arterial smooth muscle cells. Am J Physiol Heart Circ Physiol.
2003;285:H1347e1355.
(33) Ellison G. The N-methyl-D-aspartate antagonists phencyclidine, ketamine and
dizocilpine as both behavioral and anatomical models of the dementias. Brain
Res Brain Res Rev. 1995;20:250e267.
J.M. Kim et al. / Journal of Pharmacological Sciences 127 (2015) 92e102102(34) Olney JW, Labruyere J, Price MT. Pathological changes induced in cere-
brocortical neurons by phencyclidine and related drugs. Science. 1989;244:
1360e1362.
(35) Braun I, Genius J, Grunze H, Bender A, Moller HJ, Rujescu D. Alterations of
hippocampal and prefrontal GABAergic interneurons in an animal model of
psychosis induced by NMDA receptor antagonism. Schizophr Res. 2007;97:
254e263.
(36) Tamminga CA, Lahti AC, Medoff DR, Gao XM, Holcomb HH. Evaluating glu-
tamatergic transmission in schizophrenia. Ann N Y Acad Sci. 2003;1003:
113e118.
(37) Becker A, Peters B, Schroeder H, Mann T, Huether G, Grecksch G. Ketamine-
induced changes in rat behaviour: a possible animal model of schizophrenia.
Prog Neuropsychopharmacol Biol Psychiatry. 2003;27:687e700.
(38) Clarke PB, Reuben M. Inhibition by dizocilpine (MK-801) of striatal dopamine
release induced by MPTP and MPPþ: possible action at the dopamine trans-
porter. Br J Pharmacol. 1995;114:315e322.
(39) Gonzalez-Maeso J, Ang RL, Yuen T, Chan P, Weisstaub NV, Lopez-Gimenez JF,
et al. Identiﬁcation of a serotonin/glutamate receptor complex implicated in
psychosis. Nature. 2008;452:93e97.
(40) Kapur S, Seeman P. NMDA receptor antagonists ketamine and PCP have direct
effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for
models of schizophrenia. Mol Psychiatry. 2002;7:837e844.
(41) Ninan I, Kulkarni SK. 5-HT2A receptor antagonists block MK-801-induced
stereotypy and hyperlocomotion. Eur J Pharmacol. 1998;358:111e116.
(42) Yoshizawa K, Mori T, Ueno T, Nishiwaki M, Shibasaki M, Shimizu N, et al.
Involvement of serotonin receptor mechanisms in the discriminative stimulus
effects of ketamine in rats. J Pharmacol Sci. 2013;121:237e241.
(43) Albert AP, Spyer KM, Brooks PA. The effect of 5-HT and selective 5-HT receptor
agonists and antagonists on rat dorsal vagal preganglionic neurones in vitro.
Br J Pharmacol. 1996;119:519e526.
(44) D'Adamo MC, Servettini I, Guglielmi L, Di Matteo V, Di Maio R, Di Giovanni G,
et al. 5-HT2 receptors-mediated modulation of voltage-gated Kþ channels
and neurophysiopathological correlates. Exp Brain Res. 2013;230:453e462.
(45) Cogolludo A, Moreno L, Lodi F, Frazziano G, Cobeno L, Tamargo J, et al. Se-
rotonin inhibits voltage-gated Kþ currents in pulmonary artery smooth
muscle cells: role of 5-HT2A receptors, caveolin-1, and KV1.5 channel inter-
nalization. Circ Res. 2006;98:931e938.(46) Tsuneizumi T, Babb SM, Cohen BM. Drug distribution between blood and brain
as a determinant of antipsychotic drug effects. Biol Psychiatry. 1992;32:
817e824.
(47) Jeong I, Choi BH, Yoon SH, Hahn SJ. Carvedilol blocks the cloned cardiac Kv1.5
channels in a beta-adrenergic receptor-independent manner. Biochem Phar-
macol. 2012;83:497e505.
(48) Su Z, Martin R, Cox BF, Gintant G. Mesoridazine: an open-channel blocker of
human ether-a-go-go-related gene Kþ channel. J Mol Cell Cardiol. 2004;36:
151e160.
(49) Lin ZY, Chen LM, Zhang J, Pan XD, Zhu YG, Ye QY, et al. Ginsenoside Rb1
selectively inhibits the activity of L-type voltage-gated calcium channels in
cultured rat hippocampal neurons. Acta Pharmacol Sin. 2012;33:438e444.
(50) Wu SN, Hsu MC, Liao YK, Wu FT, Jong YJ, Lo YC. Evidence for inhibitory effects
of ﬂupirtine, a centrally acting analgesic, on delayed rectiﬁer k(þ) currents in
motor neuron-like cells. Evid Based Complement Alternat Med. 2012;2012:
148403.
(51) Noh HJ, Bae YM, Park SH, Kim JG, Kim B, Kim YS, et al. The vasodilatory effect
of ketamine is independent of the N-methyl-D-aspartate receptor: lack of
functional N-methyl-D-aspartate receptors in rat mesenteric artery smooth
muscle. Eur J Anaesthesiol. 2009;26:676e682.
(52) Hollmann MW, Liu HT, Hoenemann CW, Liu WH, Durieux ME. Modulation of
NMDA receptor function by ketamine and magnesium. Part II: interactions
with volatile anesthetics. Anesth Analg. 2001;92:1182e1191.
(53) Fergus DJ, Martens JR, England SK. Kv channel subunits that contribute to
voltage-gated Kþ current in renal vascular smooth muscle. Pﬂugers Arch.
2003;445:697e704.
(54) Lu Y, Hanna ST, Tang G, Wang R. Contributions of Kv1.2, Kv1.5 and Kv2.1
subunits to the native delayed rectiﬁer K(þ) current in rat mesenteric artery
smooth muscle cells. Life Sci. 2002;71:1465e1473.
(55) Thorneloe KS, Chen TT, Kerr PM, Grier EF, Horowitz B, Cole WC, et al. Mo-
lecular composition of 4-aminopyridine-sensitive voltage-gated K(þ) chan-
nels of vascular smooth muscle. Circ Res. 2001;89:1030e1037.
(56) Lazaroff MA, Taylor AD, Ribera AB. In vivo analysis of Kvbeta2 function in
Xenopus embryonic myocytes. J Physiol. 2002;541:673e683.
(57) Perez-Garcia MT, Lopez-Lopez JR, Gonzalez C. Kvbeta1.2 subunit coexpression
in HEK293 cells confers O2 sensitivity to kv4.2 but not to Shaker channels.
J Gen Physiol. 1999;113:897e907.
